Accumulation of metformin by tissues of the normal and diabetic mouse
- PMID: 8165821
- DOI: 10.3109/00498259409043220
Accumulation of metformin by tissues of the normal and diabetic mouse
Abstract
1. Tissue accumulation of the antihyperglycaemic agent metformin (dimethylbiguanide) was examined after oral administration to the normal and streptozotocin (STZ) diabetic mouse. 2. Metformin (50 mg/kg body weight containing 14C-metformin 25 microCi/kg body weight), which is stable and not metabolized, resulted in maximum plasma concentrations at 0.5 h which declined to < 5% of maximum by 24 h. Maximum plasma concentrations (mumol/l, mean +/- SE) in the hepatic portal vein (normal 51.7 +/- 5.4, STZ 61.5 +/- 8.0) were higher than in the inferior vena cava (normal 29.0 +/- 2.8, STZ 35.4 +/- 5.9). 3. The greatest accumulation of metformin occurred in tissues of the small intestine, where maximum concentrations were > 1000 mumol/kg wet weight at 0.5-2 h, but declined to < 2% of maximum by 24 h. 4. Stomach, colon, salivary gland, kidney and liver accumulated metformin more than two-fold, and concentrations of the drug in heart and skeletal (gastrocnemius) muscle were greater than plasma concentrations on some occasions up to 8 h. 5. In a separate study, i.v.-administered metformin was selectively accumulated by tissues of the small intestine. Thus, retention of metformin by tissues of the small intestine may represent a deep compartment for the drug.
Similar articles
-
Effect of metformin on glucose metabolism in mouse soleus muscle.Diabete Metab. 1986 Aug;12(4):212-8. Diabete Metab. 1986. PMID: 3770275
-
Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.Metabolism. 2006 Jul;55(7):960-71. doi: 10.1016/j.metabol.2006.03.004. Metabolism. 2006. PMID: 16784971
-
NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).Natl Toxicol Program Tech Rep Ser. 1996 Aug;383:1-370. Natl Toxicol Program Tech Rep Ser. 1996. PMID: 12692653
-
Effects of Syzygium cordatum (Hochst.) [Myrtaceae] leaf extract on plasma glucose and hepatic glycogen in streptozotocin-induced diabetic rats.J Ethnopharmacol. 2005 Mar 21;97(3):485-90. doi: 10.1016/j.jep.2004.12.005. J Ethnopharmacol. 2005. PMID: 15740884
-
Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.Int J Toxicol. 2007;26 Suppl 1:3-106. doi: 10.1080/10915810601163939. Int J Toxicol. 2007. PMID: 17365137 Review.
Cited by
-
Effects of imeglimin on mitochondrial function, AMPK activity, and gene expression in hepatocytes.Sci Rep. 2023 Jan 13;13(1):746. doi: 10.1038/s41598-023-27689-y. Sci Rep. 2023. PMID: 36639407 Free PMC article.
-
The effect of additional acarbose on metformin-associated artificially high 18F-Fluorodeoxyglucose uptake in positron emission tomography/computed tomography.Acta Diabetol. 2022 Jul;59(7):929-937. doi: 10.1007/s00592-022-01890-3. Epub 2022 Apr 16. Acta Diabetol. 2022. PMID: 35429263
-
Metformin: new understandings, new uses.Drugs. 2003;63(18):1879-94. doi: 10.2165/00003495-200363180-00001. Drugs. 2003. PMID: 12930161 Review.
-
Hydrogel-forming microneedles enhance transdermal delivery of metformin hydrochloride.J Control Release. 2018 Sep 10;285:142-151. doi: 10.1016/j.jconrel.2018.07.009. Epub 2018 Jul 7. J Control Release. 2018. PMID: 29990526 Free PMC article.
-
Therapeutic Concentrations of Metformin: A Systematic Review.Clin Pharmacokinet. 2016 Apr;55(4):439-59. doi: 10.1007/s40262-015-0323-x. Clin Pharmacokinet. 2016. PMID: 26330026 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
